Your browser doesn't support javascript.
loading
Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020-2022.
Marra, Alexandre R; Sampaio, Vanderson Souza; Ozahata, Mina Cintho; Lopes, Rafael; Brito, Anderson F; Bragatte, Marcelo; Kalil, Jorge; Miraglia, João Luiz; Malheiro, Daniel Tavares; Guozhang, Yang; Teich, Vanessa Damazio; Victor, Elivane da Silva; Pinho, João Renato Rebello; Cypriano, Adriana; Vieira, Laura Wanderly; Polonio, Miria; de Oliveira, Solange Miranda; Ricardo, Victória Catharina Volpe; Maezato, Aline Miho; Callado, Gustavo Yano; Schettino, Guilherme de Paula Pinto; de Oliveira, Ketti Gleyzer; Santana, Rúbia Anita Ferraz; Malta, Fernanda de Mello; Amgarten, Deyvid; Boechat, Ana Laura; Kobayashi, Takaaki; Perencevich, Eli; Edmond, Michael B; Rizzo, Luiz Vicente.
Afiliação
  • Marra AR; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Sampaio VS; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, United States.
  • Ozahata MC; Instituto Todos Pela Saúde, São Paulo, São Paulo, Brazil.
  • Lopes R; Instituto Todos Pela Saúde, São Paulo, São Paulo, Brazil.
  • Brito AF; Instituto Todos Pela Saúde, São Paulo, São Paulo, Brazil.
  • Bragatte M; Instituto Todos Pela Saúde, São Paulo, São Paulo, Brazil.
  • Kalil J; Instituto Todos Pela Saúde, São Paulo, São Paulo, Brazil.
  • Miraglia JL; Instituto Todos Pela Saúde, São Paulo, São Paulo, Brazil.
  • Malheiro DT; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Guozhang Y; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Teich VD; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Victor EDS; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Pinho JRR; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Cypriano A; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Vieira LW; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Polonio M; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • de Oliveira SM; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Ricardo VCV; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Maezato AM; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Callado GY; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Schettino GPP; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • de Oliveira KG; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Santana RAF; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Malta FM; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Amgarten D; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Boechat AL; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Kobayashi T; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
  • Perencevich E; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, United States.
  • Edmond MB; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, United States.
  • Rizzo LV; West Virginia University School of Medicine, Morgantown, West Virginia, United States.
Infect Control Hosp Epidemiol ; 44(12): 1972-1978, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37272468
ABSTRACT

OBJECTIVE:

To determine risk factors for the development of long coronavirus disease 2019 (COVID-19) in healthcare personnel (HCP).

METHODS:

We conducted a case-control study among HCP who had confirmed symptomatic COVID-19 working in a Brazilian healthcare system between March 1, 2020, and July 15, 2022. Cases were defined as those having long COVID according to the Centers for Disease Control and Prevention definition. Controls were defined as HCP who had documented COVID-19 but did not develop long COVID. Multiple logistic regression was used to assess the association between exposure variables and long COVID during 180 days of follow-up.

RESULTS:

Of 7,051 HCP diagnosed with COVID-19, 1,933 (27.4%) who developed long COVID were compared to 5,118 (72.6%) who did not. The majority of those with long COVID (51.8%) had 3 or more symptoms. Factors associated with the development of long COVID were female sex (OR, 1.21; 95% CI, 1.05-1.39), age (OR, 1.01; 95% CI, 1.00-1.02), and 2 or more SARS-CoV-2 infections (OR, 1.27; 95% CI, 1.07-1.50). Those infected with the SARS-CoV-2 δ (delta) variant (OR, 0.30; 95% CI, 0.17-0.50) or the SARS-CoV-2 o (omicron) variant (OR, 0.49; 95% CI, 0.30-0.78), and those receiving 4 COVID-19 vaccine doses prior to infection (OR, 0.05; 95% CI, 0.01-0.19) were significantly less likely to develop long COVID.

CONCLUSIONS:

Long COVID can be prevalent among HCP. Acquiring >1 SARS-CoV-2 infection was a major risk factor for long COVID, while maintenance of immunity via vaccination was highly protective.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Infect Control Hosp Epidemiol Assunto da revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Infect Control Hosp Epidemiol Assunto da revista: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil